Sign In / Sign Out
Navigation for Entire University
- ASU Home
- My ASU
- Colleges and Schools
- Map and Locations
More than 5 million Americans suffer from Alzheimer’s. This has profound implications for Arizona, with a population of more than 1 million people over age 65 living today that is expected to expand to 2.4 million by 2050.
To address this challenge, Arizona State University and Phoenix-based Banner Health, one of the nation’s largest nonprofit health systems, have launched a research alliance to advance the scientific study, treatement and prevention of Alzheimer's, Parkinson's and other neurodegeneratives diseases. The partnership includes the establishment of the ASU-Banner Neurodegenerative Disease Research Center at the Biodesign Institute on ASU’s Tempe campus.
Dr. Eric Reiman, CEO of Banner Research and executive director of the Banner Alzheimer’s Institute, leads the Center. The effort capitalizes on Banner’s internationally recognized programs in Alzheimer’s research and patient care and on ASU’s rapid ascension as a world-class research university. It also leverages Banner’s close working relationships with other research organizations in Arizona.
Expected to become one of the world's largest basic science centers for the study of Alzheimer's and other neurodegenerative diseases and attract the top minds in these fields, the center is an extension of the partners' work with the Arizona Alzheimer's Consortium, a leading model of statewide collaboration in biomedical research.